Talus Bio logo

Talus Bio

Discovering drugs that target the DNA regulome

Summer 2021Healthcare / Healthcare -> Drug Discovery and DeliverySeattle, WA, USA16 employees
Biotech
Genomics
Drug discovery

About

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Founders (2)

Alex Federation
Founder
Lindsay Pino
Founder

Details

Status
Active
Stage
Early
Team Size
16
Regions
United States of America, America / Canada, Remote, Partly Remote